Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 3, 2025 • 9:31 AM ET

Date/Time Source News Release
07/10/2023 10:39 PM EDT GlobeNewswire Acerus Update
05/25/2023 09:55 PM EDT GlobeNewswire Acerus Update
03/14/2023 07:30 AM EDT GlobeNewswire Acerus Announces Commencement of Court-Approved Sale and Investment Solicitation Process
01/26/2023 10:57 AM EST GlobeNewswire Acerus Files For CCAA Protection
12/26/2022 07:00 AM EST GlobeNewswire Acerus Announces Resignation of Director
12/22/2022 07:00 AM EST GlobeNewswire Acerus Announces New Loan Agreement With First Generation Capital
11/15/2022 07:30 AM EST GlobeNewswire Acerus Reports Third Quarter 2022 Financial Results
10/03/2022 07:30 AM EDT GlobeNewswire Acerus Announces Amendment to Promissory Note Due to Former Serenity Shareholders
09/21/2022 07:30 AM EDT GlobeNewswire Acerus Announces Initiation of Strategic Review
08/23/2022 07:30 AM EDT GlobeNewswire Acerus Announces Resignation of CFO Effective November 20, 2022
Page

Additional News

As of June 3, 2025 • 9:31 AM ET

Date/Time Source News Release
11/15/2022 09:07 AM EST SeekingAlpha Acerus Pharmaceuticals GAAP EPS of -$0.54, revenue of $0.77M
08/23/2022 07:41 AM EDT SeekingAlpha Acerus Pharmaceuticals CFO resigns effective November 20, 2022
08/14/2022 12:39 PM EDT SeekingAlpha Acerus Pharmaceuticals Corporation (ASPCF) CEO Edward Gudaitis on Q2 2022 Results - Earnings Call Transcript
08/09/2022 08:04 AM EDT SeekingAlpha Acerus Pharmaceuticals GAAP EPS of -$1.03, revenue of $0.76M
06/24/2022 07:38 AM EDT SeekingAlpha Acerus Pharmaceuticals increases loan facility to $37.94M
05/10/2022 07:56 AM EDT SeekingAlpha Acerus Pharmaceuticals GAAP EPS of $0.00, revenue of $0.78M
03/15/2022 11:59 AM EDT SeekingAlpha Acerus Pharmaceuticals Corporation's (ASPCF) CEO Ed Gudaitis on Q4 2021 Results - Earnings Call Transcript
03/15/2022 07:52 AM EDT SeekingAlpha Acerus Pharmaceuticals GAAP EPS of -$0.01, revenue of $0.74M
02/28/2022 08:30 AM EST SeekingAlpha Acerus to acquire Florida-based Serenity in cash/stock deal
11/11/2021 09:38 AM EST SeekingAlpha Acerus Pharmaceuticals Corporation (ASPCF) CEO Ed Gudaitis on Q3 2021 Results - Earnings Call Transcript
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.